Ground Swell Capital’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Ground Swell Capital’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1K	Buy	+53	New	+$1.61K	﹤0.01%	2333

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

MRM

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ground Swell Capital's BRLI Position: Q3 2014 in Review

Ground Swell Capital opened a new position in BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2014: 53 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2333 among its holdings.

168 funds tracked by Wall St. Rank hold BRLI as of Q3 2014.

Ground Swell Capital held 53 shares of BIO-REFERENCE LABS INC-NEW- worth $1K as of Q3 2014.
BIO-REFERENCE LABS INC-NEW- was a new Ground Swell Capital position in Q3 2014.
BIO-REFERENCE LABS INC-NEW- made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2333 holding.
168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.